Tenaya Therapeutics, Inc.
NASDAQ:TNYA
1.91 (USD) • At close October 22, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Tenaya Therapeutics, Inc. |
Symbool | TNYA |
Munteenheid | USD |
Prijs | 1.91 |
Beurswaarde | 150,678,181 |
Dividendpercentage | 0% |
52-weken bereik | 1.61 - 7.01 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Faraz Ali M.B.A. |
Website | https://www.tenayatherapeutics.com |
An error occurred while fetching data.
Over Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)